Literature DB >> 1571409

Prognostic significance of the heterogenous expression of IgG Fc receptors in B-cell chronic lymphocytic leukemia.

V Schranz1, F Gráf.   

Abstract

Receptors for the Fc part of IgG (Fc gamma R) are expressed in three forms on peripheral blood lymphocytes. The presence of the releasable form (Fc gamma R(REL.)) as well as of the two nonreleasable forms with lower (Fc gamma R(LOW)) and higher (Fc gamma R(HIGH)) cellular avidity was correlated with survival in 63 patients with B-cell chronic lymphocytic leukemia (B-CLL). High percentage of cells with Fc gamma R(LOW) as well as high "absolute" number of cells carrying the two nonreleasable forms of Fc gamma R were connected to unfavorable prognosis. Combining these three parameters, an Fc gamma R constellation was defined which pointed to a favorable prognosis (in 24 patients) when all three parameters were low, but detected short survivors when all three data were high (in 14 patients). The Fc gamma R constellation was capable of identifying patients with better or worse prognosis within groups that were homogeneous regarding some other known prognostic factors. Fc gamma R constellation as a prognostic factor was shown to be independent of age, sex, and Rai and Binet stages, but it was found to be connected with the total tumor mass score (TTM). The three forms of Fc gamma R on B cells might reflect stages of B-cell activation. Differences in Fc gamma R constellations between patients with B-CLL would thus correspond to differently activated B-cell clones with variable prognosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1571409     DOI: 10.1007/bf01697401

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  34 in total

Review 1.  IgG-Fc-receptors: ligand binding and lysis induction.

Authors:  J Gergely; G Sarmay
Journal:  Immunol Lett       Date:  1989-01-15       Impact factor: 3.685

Review 2.  Staging and therapy of chronic lymphocytic leukemia.

Authors:  K A Foon; R P Gale
Journal:  Semin Hematol       Date:  1987-10       Impact factor: 3.851

3.  Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia.

Authors:  M Sarfati; D Bron; L Lagneaux; C Fonteyn; H Frost; G Delespesse
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

4.  Immunoglobulin G-binding factors (IgG-BF) inhibit IgG secretion by, as well as proliferation of, hybridoma B cells.

Authors:  J L Teillaud; S Amigorena; J Moncuit; C Sautès; W H Fridman
Journal:  Immunol Lett       Date:  1987-11       Impact factor: 3.685

5.  Antigen-antibody complexes bound to B-lymphocyte Fc gamma receptors regulate B-lymphocyte differentiation.

Authors:  F Uher; M C Lamers; H B Dickler
Journal:  Cell Immunol       Date:  1985-10-15       Impact factor: 4.868

6.  Comparison of the (A, B, C) staging and the Rai's staging from a large prospective series (935 patients). French Cooperative Group on Chronic Lymphocytic Leukemia.

Authors: 
Journal:  Nouv Rev Fr Hematol       Date:  1988

7.  Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination.

Authors:  W Q Qiu; D de Bruin; B H Brownstein; R Pearse; J V Ravetch
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Shedding and reappearance of Fc, C3 and SRBC receptors on peripheral lymphocytes from normal donors and chronic lymphatic leukaemia (CLL) patients.

Authors:  G Sármay; L István; J Gergely
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

9.  Detection of Activation Antigens on Chronic Lymphocytic Leukaemia Cells.

Authors:  K Pálóczi; É Pócsik; R Mihalik; M Benczur; J Demeter; V Solti; G Petrányi; S R Hollan
Journal:  Leuk Lymphoma       Date:  1990

10.  Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.

Authors:  D Catovsky; J Fooks; S Richards
Journal:  Br J Haematol       Date:  1989-06       Impact factor: 6.998

View more
  2 in total

1.  Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes.

Authors:  A M Walker; D W Montgomery; S Saraiya; T W Ho; H S Garewal; J Wilson; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

2.  MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

Authors:  Masato Ito; Shinsuke Iida; Hiroshi Inagaki; Kazuya Tsuboi; Hirokazu Komatsu; Motoko Yamaguchi; Naoya Nakamura; Ritsuro Suzuki; Masao Seto; Shigeo Nakamura; Yasuo Morishima; Ryuzo Ueda
Journal:  Jpn J Cancer Res       Date:  2002-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.